Revolution Medicines, Inc. (RVMD)
NASDAQ·Healthcare·Biotechnology
$190.89
-1.04%
Mkt Cap $41.87B
Analyst Ratings
Buy
46
Hold
0
Sell
0
Price Target (67 analysts)
$247.00
Range $179.00 – $320.00
Implied Upside
+29.4%
Consensus $247.00 vs current $190.89